Last reviewed · How we verify
NCT06319534
Stellate Ganglion Block in Bulbar Palsy
NA trial testing Comprehensive rehabilitation in Bulbar Palsy in 124 participants. Completed in 5 July 2025.
5 June 2025
Quick facts
| Lead sponsor | Copka Sonpashan |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 124 |
| Start date | 23 March 2024 |
| Primary completion | 5 June 2025 |
| Estimated completion | 5 July 2025 |
| Sites | 6 locations across China |
Drugs / interventions tested
- Comprehensive rehabilitation
- Stellate ganglion block — full drug profile →
- Lidocaine Hydrochloride (Lidocaine Hydrochloride) — full drug profile →
- placebo injection
Conditions studied
- Bulbar Palsy — all drugs for Bulbar Palsy →
Sponsor
Copka Sonpashan
Who can join
18 and older, any sex, with Bulbar Palsy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a randomized controlled study, including dysphagic patients with bulbar palsy after ischemic stroke who were received in the department of rehabilitation medicine in 3 hospitals in China. All patients are randomly allocated to the observation group or the control group. Both groups are provided with comprehensive rehabilitation. Besides, the observation group additionally undergoes the stellate ganglion block. At admission and after 10-day treatment, video fluoroscopic swallowing study, ultrasound diagnostic devices, and penetration-aspiration scale, Flexible laryngoscope are used to assess swallowing function.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Effects of ultrasound-guided stellate ganglion block in poststroke bulbar palsy: a double-blind placebo-controlled trial.
Zeng H, Zhang W, Yang Y, Li Y, et al · · 2026 · PMID 41782152 · DOI 10.1186/s12916-026-04684-4
Verify or expand the search:
- PubMed search for NCT06319534
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Comprehensive rehabilitation
Trials testing the same drug.
- NCT06225076 — Efficacy of Stellate Ganglion Block in Dysphagic Patients With Bulbar Palsy After Ischemic Stroke · NA · withdrawn
- NCT06301737 — Lidocaine Injection: A Nove Block Therapy for Stroke-related Dysphagia · NA · completed
Other Copka Sonpashan trials
Trials by the same sponsor.
- NCT06328985 — Intermittent Oro-esophageal Tube Feeding in Traumatic Brain Injury Patients · NA · completed
- NCT06328894 — Effect of Different Feeding Modes on Psychological Condition and Experience in Stroke Patients · NA · completed
- NCT06328231 — The Impact of Swallowing Intervention for Elderly Community Dwellers · NA · completed
- NCT06335316 — Effect of Stellate Nerve Block in Dysphagia · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06319534 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Copka Sonpashan
- Last refreshed: 10 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06319534.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing